Orange Book product · Generic (ANDA)
CLINDAMYCIN PALMITATE HYDROCHLORIDE
CLINDAMYCIN PALMITATE HYDROCHLORIDE
At a glance
Mar 13, 2014
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 13, 2014
12 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
CLINDAMYCIN PALMITATE HYDROCHLORIDE
Strength
EQ 75MG BASE/5ML
Dosage form
FOR SOLUTION
Route
ORAL
TE code
Not listed
Application
ANDA 203513
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CLINDAMYCIN PALMITATE HYDROCHLORIDE
- 2018CLINDAMYCIN PALMITATE HYDROCHLORIDEGeneric (ANDA)
ANDA 207047 · APPCO
- 2017CLINDAMYCIN PALMITATE HYDROCHLORIDEGeneric (ANDA)
ANDA 206958 · CHARTWELL RX
- 2016CLINDAMYCIN PALMITATE HYDROCHLORIDEGeneric (ANDA)
ANDA 203063 · EXTROVIS
- 2013CLINDAMYCIN PALMITATE HYDROCHLORIDEGeneric (ANDA)
ANDA 202409 · AUROBINDO PHARMA LTD
- 2012CLINDAMYCIN PALMITATE HYDROCHLORIDEGeneric (ANDA)
ANDA 201821 · RISING
- 2010CLINDAMYCIN PALMITATE HYDROCHLORIDEGeneric (ANDA)
ANDA 090902 · PADAGIS US
- 1986CLEOCINGeneric (ANDA)
ANDA 062644 · PFIZER
- —CLEOCINGeneric (ANDA)
ANDA 061827 · PHARMACIA AND UPJOHN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
